Skip to main content
Clinical Trials/ChiCTR-EOC-15005803
ChiCTR-EOC-15005803Active, not recruitingNot Applicable

免疫缺陷病防治关键技术研究

公益性行业科研专项4 sites in 1 country1,000 target enrollmentStarted: July 1, 2014Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
1,000
Locations
4
Primary Endpoint
T、B 淋巴细胞精细免疫分型、TREC

Study Overview

Brief Summary

提供中国儿童 T、B 淋巴细胞精细免疫分型、TREC 等免疫学指标的正常参考值

Study Design

Study Type
流行病学研究
Primary Purpose
横断面

Eligibility Criteria

Ages
1 to 18 (—)
Sex
All

Inclusion Criteria

  • 0-18 岁健康中国儿童

Exclusion Criteria

  • 1.患有免疫系统、血液性疾病及过敏性疾病;2.近 4 周有感染表现;3.近 4 周内有用药史;4.近 4 周内有疫苗接种史;5.近 1 年内有输血史

Arms & Interventions

All children

Nil

Outcomes

Primary Outcomes

T、B 淋巴细胞精细免疫分型、TREC

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
公益性行业科研专项

Study Sites (4)

Loading locations...

Similar Trials